November 09, 2005 11:22 ET

Nymox Product Recommended in Today's London Daily Mirror

HASBROUCK HEIGHTS, N.J.--(CCNMatthews - Nov 9, 2005) -

Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) TobacAlert™ product received a positive independent assessment today in London's Daily Mirror. TobacAlert™ is the Company's innovative product for measuring second hand smoke exposure. The article was written by Deborah Dooley, and it emphasizes the usefulness of TobacAlert™ in assessing the potential danger and damage people face from second hand smoke exposure. The article quotes experts in the field, and gives examples of how the test has helped people.

For example, quoting from the article:


PRIMARY school assistant Chloe Jacobs, 25, is from Newport, Isle of
Wight. She lives with smoker Will Jackson, 22.

CHLOE SAYS: Although I didn't like Will smoking at home, I put up with
it. I tried to persuade him to give up, but I could see how difficult
it was. So we compromised and he never smoked upstairs.

But when his mates came round and they all sat in the front room
smoking, it was awful. I'd have to leave the room. About a month ago,
I came across the TobacAlert test on the net. I sent off for one.

The results shocked me. I registered a two - showing a high level for
a non-smoker. And when I showed it to Will, he was so upset he turned
our whole house into a smoke-free zone.

WILL SAYS: I felt really bad when Chloe showed me the hard evidence
that my smoking was harming her.

I immediately told her I'd never smoke in the house again and I've
banned all my mates from lighting up.

Now I always try to find non-smoking areas of restaurants and pubs
when we're out together.

But it also made me think that if her levels are that high as a
non-smoker, what must mine be like?

Maybe I'll even try to quit."

Nymox Pharmaceutical (NASDAQ:NYMX) makes TobacAlert™, an easy-to-use, cost-effective product that allows for on-site testing for second-hand smoke exposure. TobacAlert™ can be used at home, at school or in the workplace. No instruments are required and results are provided within minutes.

Second-hand smoke exposure is increasingly recognized as a major public health risk, particularly for children, pregnant women and people with asthma or heart disease. Second-hand smoke has been linked to increased risk of respiratory problems, lung, breast and other cancers, heart disease, and poor pregnancy outcomes and is classified as a class A carcinogen (the most serious category) by the U.S. Environmental Protection Agency. According to the California Air Resources Board, an estimated 50,000 deaths occur from second hand smoke exposure in the U.S. alone.

TobacAlert™ is available at over 5,400 CVS/pharmacy® stores across the U.S. as well as online at www.cvs.com. More information is available at www.tobacalert.com.

More information about Nymox is available at www.nymox.com, email: info@nymox.com, or 800-936-9669.

This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.

Contact Information

  • Nymox Pharmaceutical Corporation
    Roy Wolvin, 1-800-93NYMOX